IASLC Lung Cancer News (ILCN), June 2023
ILCN | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
  • From the Editors: Those in Thoracic Oncology Field Must Educate Themselves About Artificial Intelligence
  • Tumor Treating Fields May Provide Additional Treatment Option for mNSCLC Following Progression
  • International Group Consensus Statement Offers Technical Guidance for MPM Imaging
  • IASLC Announces Results of 2023 Board of Directors Election
  • In Brief for June 28, 2023
  • ADAURA Demonstrates OS Benefit with Adjuvant Osimertinib in Resectable EGFRm NSCLC
  • Data Supporting IO Before Surgery in Resectable NSCLC Grows
  • From the Editors: Defining Resectability of Non-Small Cell Lung Cancer in 2023
  • Majority of NSCLC Patients from Low Socio-Economic Areas in England Do Not Receive Novel Anti-Cancer Therapies
  • Commentary: Global Initiatives to Reduce Cancer Incidence, Mortality Must Tackle Tobacco
IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.
Powered By